Cocrystal Pharma Collaborates with the National Institute of Allergy and Infectious Diseases to Evaluate COVID-19 Protease Inhibitors

Media Type
Article
Publish or Event Date
Research Institution
Cocrystal Pharma
Short Title
Cocrystal Pharma Collaborates with the National Institute of Allergy and Infectious Diseases to Evaluate COVID-19 Protease Inhibitors
Content Coordinator
Content Manager